Page last updated: 2024-08-16

technetium tc 99m sestamibi and Parkinson Disease

technetium tc 99m sestamibi has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayabara, T; Kanzaki, N; Sato, K	1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and Parkinson Disease

Article	Year
Improved cardiac iodine-123 metaiodobenzylguanidine accumulation after drug therapy in a patient with Parkinson's disease. Clinical nuclear medicine, 1997, Volume: 22, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Coronary Circulation; Droxidopa; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Parkinson Disease; Pergolide; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon	1997

Article

Year

Improved cardiac iodine-123 metaiodobenzylguanidine accumulation after drug therapy in a patient with Parkinson's disease.

Clinical nuclear medicine, 1997, Volume: 22, Issue:10

Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Coronary Circulation; Droxidopa; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Parkinson Disease; Pergolide; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

1997